Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial

Carregando...
Imagem de Miniatura
Citações na Scopus
41
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
ARTHRITIS RESEARCH & THERAPY, v.15, n.2, article ID R46, 11p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Exercise training has emerged as a promising therapeutic strategy to counteract physical dysfunction in adult systemic lupus erythematosus. However, no longitudinal studies have evaluated the effects of an exercise training program in childhood-onset systemic lupus erythematosus (C-SLE) patients. The objective was to evaluate the safety and the efficacy of a supervised aerobic training program in improving the cardiorespiratory capacity in C-SLE patients. Methods: Nineteen physically inactive C-SLE patients were randomly assigned into two groups: trained (TR, n = 10, supervised moderate-intensity aerobic exercise program) and non-trained (NT, n = 9). Gender-,body mass index (BMI)- and age-matched healthy children were recruited as controls (C, n = 10) for baseline (PRE) measurements only. C-SLE patients were assessed at PRE and after 12 weeks of training (POST). Main measurements included exercise tolerance and cardiorespiratory measurements in response to a maximal exercise (that is, peak VO2, chronotropic reserve (CR), and the heart rate recovery (Delta HRR) (that is, the difference between HR at peak exercise and at both the first (Delta HRR1) and second (Delta HRR2) minutes of recovery after exercise). Results: The C-SLE NT patients did not present changes in any of the cardiorespiratory parameters at POST (P > 0.05). In contrast, the exercise training program was effective in promoting significant increases in time-to-exhaustion (P = 0.01; ES = 1.07), peak speed (P = 0.01; ES = 1.08), peak VO2 (P = 0.04; ES = 0.86), CR (P = 0.06; ES = 0.83), and in Delta HRR1 and Delta HRR2 (P = 0.003; ES = 1.29 and P = 0.0008; ES = 1.36, respectively) in the C-SLE TR when compared with the NT group. Moreover, cardiorespiratory parameters were comparable between C-SLE TR patients and C subjects after the exercise training intervention, as evidenced by the ANOVA analysis (P > 0.05, TR vs. C). SLEDAI-2K scores remained stable throughout the study. Conclusion: A 3-month aerobic exercise training was safe and capable of ameliorating the cardiorespiratory capacity and the autonomic function in C-SLE patients.
Palavras-chave
Referências
  1. Araujo DB, 2012, LUPUS, V21, P872, DOI 10.1177/0961203312441047
  2. Ardoin SP, 2012, NAT REV RHEUMATOL, V8, P444, DOI 10.1038/nrrheum.2012.109
  3. Aydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540
  4. Baim S, 2005, J CLIN DENSITOM, V8, P371, DOI 10.1385/JCD:8:4:371
  5. Bar-Or O, 2004, PEDIAT EXERCISE MED
  6. Benseler SM, 2007, RHEUM DIS CLIN N AM, V33, P471, DOI 10.1016/j.rdc.2007.07.008
  7. Braga A, 2005, CARDIOLOGIA EXERCICI, P128
  8. Brunner HI, 2002, ARTHRITIS RHEUM, V46, P436, DOI 10.1002/art.10072
  9. Carreno L, 1999, LUPUS, V8, P287, DOI 10.1191/096120399678847786
  10. Carvalho Maria Rosenilda P de, 2005, Arthritis Rheum, V53, P838, DOI 10.1002/art.21605
  11. Chung CP, 2007, ANN RHEUM DIS, V66, P208, DOI 10.1136/ard.2006.054973
  12. Clarke-Jenssen AC, 2005, ARTHRIT RHEUM-ARTHR, V53, P308, DOI 10.1002/art.21082
  13. Cohen J, 1988, STAT POWER ANAL BEHA, P2
  14. Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804
  15. Crabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3
  16. Daltroy LH, 1995, BRIT J RHEUMATOL, V34, P1064
  17. Dogdu O, 2010, J RHEUMATOL, V37, P2511, DOI 10.3899/jrheum.100163
  18. do Prado DML, 2011, LUPUS, V20, P717, DOI 10.1177/0961203310397081
  19. El Magadmi M, 2006, J RHEUMATOL, V33, P50
  20. Gladman DD, 2002, J RHEUMATOL, V29, P288
  21. Gonzalez B, 2005, LUPUS, V14, P918, DOI 10.1191/0961203303lu2183xx
  22. Gualano B, 2010, AUTOIMMUN REV, V9, P569, DOI 10.1016/j.autrev.2010.04.001
  23. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  24. Hoffman IEA, 2009, ANN RHEUM DIS, V68, P412, DOI 10.1136/ard.2008.094813
  25. Houghton KM, 2008, ARTHRIT RHEUM-ARTHR, V59, P537, DOI 10.1002/art.23534
  26. Kamphuis S, 2010, NAT REV RHEUMATOL, V6, P538, DOI 10.1038/nrrheum.2010.121
  27. Keteyian SJ, 1999, AM HEART J, V138, P233, DOI 10.1016/S0002-8703(99)70106-7
  28. Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681
  29. Levy DM, 2012, PEDIATR CLIN N AM, V59, P345, DOI 10.1016/j.pcl.2012.03.007
  30. Machado FA, 2011, ARQ BRAS CARDIOL, V97, P136
  31. Miossi R, 2012, ARTHRIT CARE RES, V64, P1159, DOI 10.1002/acr.21678
  32. Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392
  33. Omori C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-270
  34. Omori CH, 2012, ARTHRIT CARE RES, V64, P1186, DOI 10.1002/acr.21684
  35. Prado DM, 2011, MED SCI SPORT EXER, V43, P2221, DOI 10.1249/MSS.0b013e318223b177
  36. Ramsey-Goldman R, 2000, ARTHRIT CARE RES, V13, P262, DOI 10.1002/1529-0131(200010)13:5<262::AID-ANR4>3.0.CO;2-8
  37. ROBBNICHOLSON LC, 1989, BRIT J RHEUMATOL, V28, P500
  38. Rosenwinkel Eric T., 2001, Cardiology Clinics, V19, P369, DOI 10.1016/S0733-8651(05)70223-X
  39. ROWLAND TW, 1993, PEDIATRIC LABORATORY EXERCISE TESTING, P19
  40. Stephens S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1399, DOI 10.1002/art.24115
  41. Taylor A, 1997, J BONE MINER RES, V12, P652, DOI 10.1359/jbmr.1997.12.4.652
  42. Tench C, 2002, J RHEUMATOL, V29, P474
  43. Tench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289